Primary completion date for Phase 1 and 2 is: May 2026.
suffice to say there are multiple share price inflection points between and then and if the toxicity and efficacy results are anywhere near the pre clinical data, this company will get taken over…we should have prelim data in a few months so watch this space….
- Forums
- ASX - By Stock
- Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial
CHM
chimeric therapeutics limited
Add to My Watchlist
25.0%
!
0.3¢

Primary completion date for Phase 1 and 2 is: May 2026.suffice...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $6.045M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.3¢ | $22.28K | 6.311M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
78 | 84735861 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 86304338 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
71 | 80251196 | 0.003 |
24 | 24996485 | 0.002 |
12 | 52464000 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 86304338 | 23 |
0.005 | 33049651 | 21 |
0.006 | 12474007 | 15 |
0.007 | 6512518 | 7 |
0.008 | 7317101 | 5 |
Last trade - 14.27pm 25/07/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online